|
My favourite molecule: Polyamines, chromatin structure and transcription
|
journal
|
August 1993 |
|
Preventing Cancer by Inhibiting Ornithine Decarboxylase: A Comparative Perspective on Synthetic vs. Natural Drugs
|
journal
|
March 2024 |
|
Mammalian polyamine metabolism and function
|
journal
|
September 2009 |
|
Development and testing of a general amber force field
|
journal
|
January 2004 |
|
Exploring protein native states and large-scale conformational changes with a modified generalized born model
|
journal
|
March 2004 |
|
Comparison of multiple Amber force fields and development of improved protein backbone parameters
|
journal
|
November 2006 |
|
Crystal structure of human ornithine decarboxylase at 2.1 å resolution: structural insights to antizyme binding
|
journal
|
January 2000 |
|
Chemoprevention of Prostate Cancer with the Polyamine Synthesis Inhibitor Difluoromethylornithine
|
book
|
January 2014 |
|
c-myc Transactivates the Ornithine Decarboxylase Gene
|
book
|
January 1992 |
|
Neuroblastoma: Ornithine Decarboxylase and Polyamines are Novel Targets for Therapeutic Intervention
|
book
|
October 2011 |
|
Pharmacological properties of the ornithine decarboxylase inhibitor 3-aminooxy-1-propanamine and several structural analogues
|
journal
|
January 1993 |
|
Chromatin remodeling by polyamines and polyamine analogs
|
journal
|
July 2013 |
|
Variability in docking success rates due to dataset preparation
|
journal
|
May 2012 |
|
1-Aminooxy-3-aminopropane, a new and potent inhibitor of polyamine biosynthesis that inhibits ornithine decarboxylase, adenosylmethionine decarboxylase and spermidine synthase
|
journal
|
July 1985 |
|
Conformational Restriction and/or Steric Hindrance in Medicinal Chemistry
|
book
|
January 2003 |
|
Mammalian mitochondrial inner membrane cationic and neutral amino acid carriers
|
journal
|
August 2000 |
|
Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: a multicentre, randomised, phase III, non-inferiority trial
|
journal
|
July 2009 |
|
Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings 1PII of original article: S0169-409X(96)00423-1. The article was originally published in Advanced Drug Delivery Reviews 23 (1997) 3–25. 1
|
journal
|
March 2001 |
|
BDDCS, the Rule of 5 and drugability
|
journal
|
June 2016 |
|
Selective delivery of 2-hydroxy APA to Trypanosoma brucei using the melamine motif
|
journal
|
August 2010 |
|
Lipophilicity screening of novel drug-like compounds and comparison to clogP
|
journal
|
October 2012 |
|
Polyamines: metabolism and implications in human diseases
|
journal
|
April 2005 |
|
Lead- and drug-like compounds: the rule-of-five revolution
|
journal
|
December 2004 |
|
Inhibition of polyamine biosynthesis preserves β cell function in type 1 diabetes
|
journal
|
November 2023 |
|
Target-Based Evaluation of “Drug-Like” Properties and Ligand Efficiencies
|
journal
|
May 2021 |
|
Facts, Patterns, and Principles in Drug Discovery: Appraising the Rule of 5 with Measured Physicochemical Data
|
journal
|
April 2020 |
|
Predicting a Drug’s Membrane Permeability: A Computational Model Validated With in Vitro Permeability Assay Data
|
journal
|
May 2017 |
|
Structure and Enzymatic Activity of an Intellectual Disability-Associated Ornithine Decarboxylase Variant, G84R
|
journal
|
September 2022 |
|
Equilibrium acidities in dimethyl sulfoxide solution
|
journal
|
December 1988 |
|
Altering the Reaction Specificity of Eukaryotic Ornithine Decarboxylase † , ‡
|
journal
|
September 2000 |
|
X-ray Structure of Ornithine Decarboxylase from Trypanosoma brucei : The Native Structure and the Structure in Complex with α-Difluoromethylornithine † , ‡
|
journal
|
November 1999 |
|
A Knowledge-Based Approach in Designing Combinatorial or Medicinal Chemistry Libraries for Drug Discovery. 1. A Qualitative and Quantitative Characterization of Known Drug Databases
|
journal
|
January 1999 |
|
Catalytic irreversible inhibition of mammalian ornithine decarboxylase (E.C.4.1.1.17) by substrate and product analogs
|
journal
|
April 1978 |
|
2-Substituted 3-(aminooxy)propanamines as inhibitors of ornithine decarboxylase: synthesis and biological activity
|
journal
|
April 1992 |
|
Physicochemical Determinants of Passive Membrane Permeability: Role of Solute Hydrogen-Bonding Potential and Volume
|
journal
|
October 2001 |
|
In Silico Prediction of Membrane Permeability from Calculated Molecular Parameters
|
journal
|
January 2005 |
|
The Effect of Acid Strength on the Mitsunobu Esterification Reaction: Carboxyl vs Hydroxyl Reactivity
|
journal
|
January 1996 |
|
Relationship of Octanol/Water Partition Coefficient and Molecular Weight to Cellular Permeability and Partitioning in S49 Lymphoma Cells
|
journal
|
November 1984 |
|
Polyamines and cancer: old molecules, new understanding
|
journal
|
October 2004 |
|
Targeting polyamine metabolism and function in cancer and other hyperproliferative diseases
|
journal
|
May 2007 |
|
The influence of lead discovery strategies on the properties of drug candidates
|
journal
|
March 2009 |
|
The role of ligand efficiency metrics in drug discovery
|
journal
|
January 2014 |
|
Phase 1 study of high-dose DFMO, celecoxib, cyclophosphamide and topotecan for patients with relapsed neuroblastoma: a New Approaches to Neuroblastoma Therapy trial
|
journal
|
January 2024 |
|
Polyamine metabolism and cancer: treatments, challenges and opportunities
|
journal
|
September 2018 |
|
Polyamines in cancer: integrating organismal metabolism and antitumour immunity
|
journal
|
April 2022 |
|
Advances in covalent drug discovery
|
journal
|
August 2022 |
|
Key role for p27Kip1, retinoblastoma protein Rb, and MYCN in polyamine inhibitor-induced G1 cell cycle arrest in MYCN-amplified human neuroblastoma cells
|
journal
|
June 2005 |
|
Structural basis of binding and inhibition of ornithine decarboxylase by 1-amino-oxy-3-aminopropane
|
journal
|
December 2021 |
|
A structural insight into the inhibition of human and Leishmania donovani ornithine decarboxylases by 1-amino-oxy-3-aminopropane
|
journal
|
June 2007 |
|
Polyamine catabolism and disease
|
journal
|
July 2009 |
|
Polyamines and neoplastic growth
|
journal
|
March 2007 |
|
A perspective of polyamine metabolism
|
journal
|
November 2003 |
|
A macromolecular inhibitor of the antizyme to ornithine decarboxylase
|
journal
|
June 1982 |
|
Feedback regulation of S-adenosylmethionine decarboxylase synthesis
|
journal
|
February 1989 |
|
Effect of 1-amino-oxy-3-aminopropane on polyamine metabolism and growth of L1210 cells
|
journal
|
October 1989 |
|
Enantioselective Fluorination of Spirocyclic β-Prolinals Using Enamine Catalysis
|
journal
|
November 2016 |
|
The ornithine decarboxylase gene is a transcriptional target of c-Myc.
|
journal
|
August 1993 |
|
The maximal affinity of ligands
|
journal
|
August 1999 |
|
Discovery of Potent and Selective Inhibitors of Trypanosoma brucei Ornithine Decarboxylase
|
journal
|
May 2010 |
|
Functions of Polyamines in Mammals
|
journal
|
June 2016 |
|
Polyamine synthesis as a target of MYC oncogenes
|
journal
|
November 2018 |
|
Nifurtimox-Eflornithine Combination Therapy for Second-Stage Gambiense Human African Trypanosomiasis: Médecins Sans Frontières Experience in the Democratic Republic of the Congo
|
journal
|
October 2012 |
|
Chemoprevention, Risk Reduction, Therapeutic Prevention, or Preventive Therapy?
|
journal
|
November 2010 |
|
Uptake of 3H-Labeled 1-Aminooxy-3-Aminopropane by Baby Hamster Kidney Cells1
|
journal
|
June 1990 |
|
The rational discovery of multipurpose inhibitors of the ornithine decarboxylase
|
journal
|
August 2020 |
|
Bachmann–Bupp syndrome and treatment
|
journal
|
July 2023 |
|
Medical treatment of hirsutism
|
journal
|
September 2008 |
|
Improvement of dermatological symptoms in patients with Bachmann–Bupp syndrome using difluoromethylornithine treatment
|
journal
|
November 2022 |
|
Elucidating Human Phosphatase-Substrate Networks
|
journal
|
May 2013 |
|
3-Aminooxy-1-Aminopropane and Derivatives Have an Antiproliferative Effect on Cultured Plasmodium falciparum by Decreasing Intracellular Polyamine Concentrations
|
journal
|
July 2005 |
|
Differential Mechanisms for the Involvement of Polyamines and Hypusinated eIF5A in Ebola Virus Gene Expression
|
journal
|
October 2018 |
|
Inhibition of Polyamine Biosynthesis Is a Broad-Spectrum Strategy against RNA Viruses
|
journal
|
November 2016 |
|
ODC1 Is a Critical Determinant of MYCN Oncogenesis and a Therapeutic Target in Neuroblastoma
|
journal
|
December 2008 |
|
Ornithine Decarboxylase Inhibition by α-Difluoromethylornithine Activates Opposing Signaling Pathways via Phosphorylation of Both Akt/Protein Kinase B and p27Kip1 in Neuroblastoma
|
journal
|
December 2008 |
|
Targeting Ornithine Decarboxylase Impairs Development of MYCN-Amplified Neuroblastoma
|
journal
|
January 2009 |
|
Herbacetin Is a Novel Allosteric Inhibitor of Ornithine Decarboxylase with Antitumor Activity
|
journal
|
February 2016 |
|
The Effect of Difluoromethylornithine on Decreasing Prostate Size and Polyamines in Men: Results of a Year-Long Phase IIb Randomized Placebo-Controlled Chemoprevention Trial
|
journal
|
February 2008 |
|
Polyamine Antagonist Therapies Inhibit Neuroblastoma Initiation and Progression
|
journal
|
August 2016 |
|
New transition state–based inhibitor for human ornithine decarboxylase inhibits growth of tumor cells
|
journal
|
June 2007 |
|
Difluoromethylornithine Plus Sulindac for the Prevention of Sporadic Colorectal Adenomas: A Randomized Placebo-Controlled, Double-Blind Trial
|
journal
|
April 2008 |
|
Percutaneous Absorption and Pharmacokinetics of Eflornithine HCl 13.9% Cream in Women with Unwanted Facial Hair
|
journal
|
September 2001 |
|
Eflornithine as Postimmunotherapy Maintenance in High-Risk Neuroblastoma: Externally Controlled, Propensity Score–Matched Survival Outcome Comparisons
|
journal
|
January 2024 |
|
Three Drug Combinations for Late-Stage Trypanosoma brucei gambiense Sleeping Sickness: A Randomized Clinical Trial in Uganda
|
journal
|
December 2006 |
|
A Phase I Trial of DFMO Targeting Polyamine Addiction in Patients with Relapsed/Refractory Neuroblastoma
|
journal
|
May 2015 |
|
Difluoromethylornithine rebalances aberrant polyamine ratios in Snyder–Robinson syndrome
|
journal
|
September 2023 |
|
Fundamental Methods in Drug Permeability, pKa, LogP and LogDx Determination
|
journal
|
January 2019 |
|
Targeting Polyamine Metabolism for Control of Human Viral Diseases
|
journal
|
December 2020 |
|
Monitoring the use of nifurtimox-eflornithine combination therapy (NECT) in the treatment of second stage gambiense human African trypanosomiasis
|
journal
|
August 2012 |
|
The Use of Conformational Restriction in Medicinal Chemistry
|
journal
|
October 2019 |
The Molecular Role of Polyamines in Age-Related Diseases: An Update
- Jimenez Gutierrez, Guadalupe Elizabeth; Borbolla Jiménez, Fabiola V.; Muñoz, Luis G.
-
International Journal of Molecular Sciences, Vol. 24, Issue 22
https://doi.org/10.3390/ijms242216469
|
journal
|
November 2023 |
|
Polyamines and Their Metabolism: From the Maintenance of Physiological Homeostasis to the Mediation of Disease
|
journal
|
July 2022 |
|
Translational development of difluoromethylornithine (DFMO) for the treatment of neuroblastoma
|
journal
|
July 2015 |
|
Conformational restriction: an effective tactic in 'follow-on'-based drug discovery
|
journal
|
May 2014 |
|
Repurposing eflornithine to treat a patient with a rare ODC1 gain-of-function variant disease
|
journal
|
July 2021 |